Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
25
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| BB BIOTECH AG | 10% Owner | 22 | $42.56M | $844.7K | 2024-11-14 |
| Gruia Gabriela | Interim Chief Medical Officer | 5 | $0 | $0 | 2024-09-27 |
| Sanders Corazon (Corsee) D. | Director | 6 | $0 | $0 | 2024-09-27 |
| LALANDE KEVIN M. | Director, 10% Owner | 17 | $198.4K | $11.48M | 2024-09-27 |
| SELICK HAROLD E | Director | 8 | $0 | $0 | 2024-09-27 |
| HOFFMANN DAVE | Director | 8 | $0 | $0 | 2024-09-27 |
| BIOTECH TARGET N V | 10% Owner | 17 | $14.53M | $0 | 2024-04-02 |
| Kim Jason S. | See remarks | 16 | $0 | $23.2K | 2024-01-23 |
| Voi Maurizio | Chief Medical Officer | 2 | $0 | $0 | 2024-01-23 |
| Poma Eric E | See remarks | 19 | $0 | $0 | 2024-01-23 |
| Lanfear Jonathan | Director | 3 | $0 | $0 | 2023-10-27 |
| Waltzman Roger J. | See remarks | 5 | $0 | $0 | 2023-02-15 |
| McLennan Sean | See remarks | 2 | $24.6K | $0 | 2022-06-16 |
| Cunningham Joe H | 10% Owner | 3 | $198.4K | $0 | 2022-06-15 |
| Hirsch David | Director, 10% Owner | 11 | $17.00M | $0 | 2022-06-03 |
| Morenstein Scott D | Director | 7 | $6.75M | $0 | 2021-06-03 |
| Cutler Adam D. | See remarks | 5 | $0 | $0 | 2021-02-15 |
| SHV Annex Services, LP | 10% Owner | 1 | $0 | $6.53M | 2020-09-16 |
| Longitude Venture Partners III, L.P. | 10% Owner | 3 | $7.50M | $37.6K | 2020-08-28 |
| ENRIGHT PATRICK G | 10% Owner | 4 | $0 | $0 | 2020-05-26 |
| SHV Management Services, LLC | 10% Owner | 1 | $0 | $4.95M | 2020-05-20 |
| SANTE HEALTH VENTURES I LP | 10% Owner | 1 | $0 | $0 | 2020-04-30 |
| Longitude Capital Partners III, LLC | 10% Owner | 1 | $7.50M | $0 | 2019-11-25 |
| CAXTON CORP | Director | 1 | $86.3K | $0 | 2018-12-26 |
| Tammenoms Bakker Juliet | 10% Owner | 1 | $2.01M | $0 | 2018-09-21 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| BB BIOTECH AG | 10% Owner | S Sale | 2024-11-14 | 2024-11-18 | 1,279,820 | $0.66 | $844.7K | 0 | SEC↗ |
| Sanders Corazon (Corsee) D. | Director | A Award deriv | 2024-09-27 | 2024-09-30 | 1,000 | — | $0 | 1,000 | SEC↗ |
| HOFFMANN DAVE | Director | A Award deriv | 2024-09-27 | 2024-09-30 | 1,000 | — | $0 | 1,000 | SEC↗ |
| SELICK HAROLD E | Director | A Award deriv | 2024-09-27 | 2024-09-30 | 1,000 | — | $0 | 1,000 | SEC↗ |
| Gruia Gabriela | Director | A Award deriv | 2024-09-27 | 2024-09-30 | 1,000 | — | $0 | 1,000 | SEC↗ |
| LALANDE KEVIN M. | Director, 10% Owner | A Award deriv | 2024-09-27 | 2024-09-30 | 1,000 | — | $0 | 1,000 | SEC↗ |
| BB BIOTECH AG | 10% Owner | P Buy deriv | 2024-04-02 | 2024-11-18 | 769,334 | $0.13 | $100.0K | 769,334 | SEC↗ |
| BB BIOTECH AG | 10% Owner | P Buy deriv | 2024-04-02 | 2024-11-18 | 134,667 | $2.35 | $316.5K | 134,667 | SEC↗ |
| LALANDE KEVIN M. | Director, 10% Owner | A Award deriv | 2024-04-02 | 2024-04-04 | 402,077 | $2.35 | $944.9K | 402,077 | SEC↗ |
| LALANDE KEVIN M. | Director, 10% Owner | A Award deriv | 2024-04-02 | 2024-04-04 | 1,154,154 | $0.13 | $150.0K | 1,154,154 | SEC↗ |
| BIOTECH TARGET N V | 10% Owner | P Buy deriv | 2024-04-02 | 2024-04-04 | 134,667 | $2.35 | $316.5K | 134,667 | SEC↗ |
| BIOTECH TARGET N V | 10% Owner | P Buy deriv | 2024-04-02 | 2024-04-04 | 769,334 | $0.13 | $100.0K | 769,334 | SEC↗ |
| LALANDE KEVIN M. | Director, 10% Owner | A Award | 2024-04-02 | 2024-04-04 | 175,000 | $2.35 | $411.3K | 175,000 | SEC↗ |
| BIOTECH TARGET N V | 10% Owner | P Buy | 2024-04-02 | 2024-04-04 | 250,000 | $2.35 | $587.5K | 1,279,820 | SEC↗ |
| Poma Eric E | See remarks | A Award deriv | 2024-01-23 | 2024-01-25 | 23,333 | — | $0 | 23,333 | SEC↗ |
| Kim Jason S. | Chief Financial Officer | A Award deriv | 2024-01-23 | 2024-01-25 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Voi Maurizio | Chief Medical Officer | A Award deriv | 2024-01-23 | 2024-01-25 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Voi Maurizio | Chief Medical Officer | A Award deriv | 2023-10-31 | 2023-11-01 | 11,333 | — | $0 | 11,333 | SEC↗ |
| Gruia Gabriela | Director | A Award deriv | 2023-10-27 | 2023-10-31 | 1,000 | — | $0 | 1,000 | SEC↗ |
| HOFFMANN DAVE | Director | A Award deriv | 2023-10-27 | 2023-10-31 | 1,000 | — | $0 | 1,000 | SEC↗ |
| LALANDE KEVIN M. | Director, 10% Owner | A Award deriv | 2023-10-27 | 2023-10-31 | 1,000 | — | $0 | 1,000 | SEC↗ |
| Lanfear Jonathan | Director | A Award deriv | 2023-10-27 | 2023-10-31 | 1,000 | — | $0 | 1,000 | SEC↗ |
| Sanders Corazon (Corsee) D. | Director | A Award deriv | 2023-10-27 | 2023-10-31 | 1,000 | — | $0 | 1,000 | SEC↗ |
| SELICK HAROLD E | Director | A Award deriv | 2023-10-27 | 2023-10-31 | 1,000 | — | $0 | 1,000 | SEC↗ |
| Gruia Gabriela | Interim Chief Medical Office | A Award deriv | 2023-08-31 | 2023-08-31 | 11,666 | — | $0 | 11,666 | SEC↗ |
| BB BIOTECH AG | 10% Owner | P Buy | 2023-07-17 | 2023-07-19 | 4,255,319 | $0.47 | $2.00M | 15,447,322 | SEC↗ |
| Kim Jason S. | See remarks | A Award deriv | 2023-02-15 | 2023-02-17 | 170,000 | — | $0 | 170,000 | SEC↗ |
| Waltzman Roger J. | See remarks | A Award deriv | 2023-02-15 | 2023-02-17 | 170,000 | — | $0 | 170,000 | SEC↗ |
| Poma Eric E | See remarks | A Award deriv | 2023-02-15 | 2023-02-17 | 400,000 | — | $0 | 400,000 | SEC↗ |
| Kim Jason S. | See remarks | M Exercise deriv | 2022-07-07 | 2022-07-11 | 12,089 | — | $0 | 0 | SEC↗ |
| Kim Jason S. | See remarks | M Exercise | 2022-07-07 | 2022-07-11 | 12,089 | $0.71 | $8.6K | 95,493 | SEC↗ |
| McLennan Sean | See remarks | P Buy | 2022-06-16 | 2022-06-21 | 30,000 | $0.82 | $24.6K | 30,000 | SEC↗ |
| Cunningham Joe H | 10% Owner | P Buy | 2022-06-15 | 2022-06-21 | 62,000 | $0.89 | $55.2K | 222,000 | SEC↗ |
| LALANDE KEVIN M. | Director, 10% Owner | P Buy | 2022-06-15 | 2022-06-21 | 62,000 | $0.89 | $55.2K | 222,000 | SEC↗ |
| Cunningham Joe H | 10% Owner | P Buy | 2022-06-14 | 2022-06-21 | 60,000 | $0.87 | $52.2K | 160,000 | SEC↗ |
| LALANDE KEVIN M. | Director, 10% Owner | P Buy | 2022-06-14 | 2022-06-21 | 60,000 | $0.87 | $52.2K | 160,000 | SEC↗ |
| Cunningham Joe H | 10% Owner | P Buy | 2022-06-13 | 2022-06-21 | 100,000 | $0.91 | $91.0K | 100,000 | SEC↗ |
| LALANDE KEVIN M. | Director, 10% Owner | P Buy | 2022-06-13 | 2022-06-21 | 100,000 | $0.91 | $91.0K | 100,000 | SEC↗ |
| SELICK HAROLD E | Director | A Award deriv | 2022-06-03 | 2022-06-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Hirsch David | Director | A Award deriv | 2022-06-03 | 2022-06-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| HOFFMANN DAVE | Director | A Award deriv | 2022-06-03 | 2022-06-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| LALANDE KEVIN M. | Director, 10% Owner | A Award deriv | 2022-06-03 | 2022-06-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Lanfear Jonathan | Director | A Award deriv | 2022-06-03 | 2022-06-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Gruia Gabriela | Director | A Award deriv | 2022-06-03 | 2022-06-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Sanders Corazon (Corsee) D. | Director | A Award deriv | 2022-06-03 | 2022-06-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BIOTECH TARGET N V | 10% Owner | P Buy | 2022-05-16 | 2022-05-18 | 200,000 | $1.18 | $236.0K | 11,192,003 | SEC↗ |
| Poma Eric E | See remarks | M Exercise deriv | 2022-04-27 | 2022-04-29 | 27,325 | — | $0 | 0 | SEC↗ |
| Poma Eric E | See remarks | M Exercise deriv | 2022-04-27 | 2022-04-29 | 6,831 | — | $0 | 0 | SEC↗ |
| Poma Eric E | See remarks | M Exercise | 2022-04-27 | 2022-04-29 | 6,831 | $0.71 | $4.9K | 250,290 | SEC↗ |
| Poma Eric E | See remarks | M Exercise | 2022-04-27 | 2022-04-29 | 27,325 | $0.71 | $19.4K | 277,615 | SEC↗ |
| Gruia Gabriela | Director | A Award deriv | 2022-03-01 | 2022-03-02 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Kim Jason S. | See remarks | A Award deriv | 2022-02-15 | 2022-02-17 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Poma Eric E | See remarks | A Award deriv | 2022-02-15 | 2022-02-17 | 300,000 | — | $0 | 300,000 | SEC↗ |
| McLennan Sean | See remarks | A Award deriv | 2022-02-15 | 2022-02-17 | 85,000 | — | $0 | 85,000 | SEC↗ |
| Waltzman Roger J. | See remarks | A Award deriv | 2022-02-15 | 2022-02-17 | 125,000 | — | $0 | 125,000 | SEC↗ |
| BB BIOTECH AG | 10% Owner | P Buy | 2022-01-06 | 2022-01-10 | 200,000 | $4.04 | $808.0K | 10,992,003 | SEC↗ |
| BB BIOTECH AG | 10% Owner | P Buy | 2021-09-21 | 2021-09-23 | 750,000 | $6.00 | $4.50M | 10,792,003 | SEC↗ |
| BIOTECH TARGET N V | 10% Owner | P Buy | 2021-09-16 | 2021-09-20 | 100,000 | $6.13 | $613.0K | 10,042,003 | SEC↗ |
| BB BIOTECH AG | 10% Owner | P Buy | 2021-07-27 | 2021-07-28 | 75,000 | $7.09 | $531.8K | 9,942,003 | SEC↗ |
| BB BIOTECH AG | 10% Owner | P Buy | 2021-07-26 | 2021-07-28 | 80,000 | $7.00 | $560.0K | 9,867,003 | SEC↗ |
| BIOTECH TARGET N V | 10% Owner | P Buy | 2021-07-20 | 2021-07-21 | 125,000 | $7.13 | $891.3K | 9,787,003 | SEC↗ |
| BIOTECH TARGET N V | 10% Owner | P Buy | 2021-07-19 | 2021-07-21 | 119,382 | $6.96 | $830.9K | 9,662,003 | SEC↗ |
| Poma Eric E | See remarks | M Exercise deriv | 2021-07-06 | 2021-07-07 | 3,563 | — | $0 | 0 | SEC↗ |
| Poma Eric E | See remarks | M Exercise | 2021-07-06 | 2021-07-07 | 3,563 | $0.71 | $2.5K | 243,459 | SEC↗ |
| Kim Jason S. | See remarks | M Exercise deriv | 2021-06-28 | 2021-06-29 | 32,038 | — | $0 | 0 | SEC↗ |
| Kim Jason S. | See remarks | M Exercise | 2021-06-28 | 2021-06-29 | 32,038 | $0.71 | $22.7K | 86,174 | SEC↗ |
| Kim Jason S. | See remarks | S Sale | 2021-06-28 | 2021-06-29 | 2,770 | $8.36 | $23.2K | 83,404 | SEC↗ |
| Lanfear Jonathan | Director | A Award deriv | 2021-06-03 | 2021-06-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| LALANDE KEVIN M. | Director, 10% Owner | A Award deriv | 2021-06-03 | 2021-06-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Hirsch David | Director | A Award deriv | 2021-06-03 | 2021-06-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Sanders Corazon (Corsee) D. | Director | A Award deriv | 2021-06-03 | 2021-06-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Morenstein Scott D | Director | A Award deriv | 2021-06-03 | 2021-06-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SELICK HAROLD E | Director | A Award deriv | 2021-06-03 | 2021-06-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| HOFFMANN DAVE | Director | A Award deriv | 2021-06-03 | 2021-06-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BB BIOTECH AG | 10% Owner | P Buy | 2021-04-19 | 2021-04-21 | 40,852 | $8.08 | $330.1K | 9,542,621 | SEC↗ |
| BB BIOTECH AG | 10% Owner | P Buy | 2021-04-15 | 2021-04-19 | 150,000 | $8.62 | $1.29M | 9,501,769 | SEC↗ |
| BIOTECH TARGET N V | 10% Owner | P Buy | 2021-04-14 | 2021-04-15 | 150,000 | $8.37 | $1.26M | 9,351,769 | SEC↗ |
| BIOTECH TARGET N V | 10% Owner | P Buy | 2021-04-13 | 2021-04-15 | 100,000 | $7.81 | $781.0K | 9,201,769 | SEC↗ |
| BB BIOTECH AG | 10% Owner | P Buy | 2021-04-12 | 2021-04-13 | 50,000 | $8.02 | $401.0K | 9,101,769 | SEC↗ |
| BB BIOTECH AG | 10% Owner | P Buy | 2021-04-09 | 2021-04-13 | 235,664 | $8.23 | $1.94M | 9,051,769 | SEC↗ |
| BIOTECH TARGET N V | 10% Owner | P Buy | 2021-04-08 | 2021-04-09 | 300,000 | $8.22 | $2.47M | 8,816,105 | SEC↗ |
| BIOTECH TARGET N V | 10% Owner | P Buy | 2021-04-07 | 2021-04-09 | 200,000 | $8.24 | $1.65M | 8,516,105 | SEC↗ |
| BB BIOTECH AG | 10% Owner | P Buy | 2021-04-05 | 2021-04-07 | 200,000 | $9.44 | $1.89M | 8,316,105 | SEC↗ |
| BB BIOTECH AG | 10% Owner | P Buy | 2021-03-29 | 2021-03-31 | 80,000 | $11.45 | $916.0K | 8,116,105 | SEC↗ |
| BB BIOTECH AG | 10% Owner | P Buy | 2021-02-24 | 2021-02-25 | 75,000 | $11.48 | $861.0K | 8,036,105 | SEC↗ |
| BB BIOTECH AG | 10% Owner | P Buy | 2021-02-23 | 2021-02-25 | 235,004 | $11.29 | $2.65M | 7,961,105 | SEC↗ |
| BB BIOTECH AG | 10% Owner | P Buy | 2021-02-18 | 2021-02-19 | 1,185,770 | $12.65 | $15.00M | 7,726,101 | SEC↗ |
| Poma Eric E | See remarks | A Award deriv | 2021-02-15 | 2021-02-17 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Kim Jason S. | See remarks | A Award deriv | 2021-02-15 | 2021-02-17 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Waltzman Roger J. | See remarks | A Award deriv | 2021-02-15 | 2021-02-17 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Cutler Adam D. | See remarks | A Award deriv | 2021-02-15 | 2021-02-17 | 125,000 | — | $0 | 125,000 | SEC↗ |
| BIOTECH TARGET N V | 10% Owner | P Buy | 2021-02-01 | 2021-02-03 | 80,000 | $11.69 | $935.2K | 6,540,331 | SEC↗ |
| BIOTECH TARGET N V | 10% Owner | P Buy | 2021-01-29 | 2021-02-01 | 80,000 | $11.94 | $955.2K | 6,460,331 | SEC↗ |
| BB BIOTECH AG | 10% Owner | P Buy | 2020-12-10 | 2020-12-11 | 170,000 | $8.18 | $1.39M | 6,380,331 | SEC↗ |
| BB BIOTECH AG | 10% Owner | P Buy | 2020-12-10 | 2020-12-11 | 150,000 | $8.39 | $1.26M | 6,210,331 | SEC↗ |
| BB BIOTECH AG | 10% Owner | P Buy | 2020-12-09 | 2020-12-11 | 125,000 | $8.62 | $1.08M | 6,060,331 | SEC↗ |
| BIOTECH TARGET N V | 10% Owner | P Buy | 2020-11-10 | 2020-11-12 | 80,000 | $9.16 | $732.8K | 5,935,331 | SEC↗ |
| BIOTECH TARGET N V | 10% Owner | P Buy | 2020-11-09 | 2020-11-12 | 80,000 | $9.05 | $724.0K | 5,855,331 | SEC↗ |
| BB BIOTECH AG | 10% Owner | P Buy | 2020-11-06 | 2020-11-09 | 470,335 | $8.33 | $3.92M | 5,775,331 | SEC↗ |
| BB BIOTECH AG | 10% Owner | P Buy | 2020-11-05 | 2020-11-09 | 75,000 | $10.86 | $814.5K | 5,304,996 | SEC↗ |
| BIOTECH TARGET N V | 10% Owner | P Buy | 2020-10-30 | 2020-11-04 | 80,000 | $8.83 | $706.4K | 5,229,996 | SEC↗ |
| BIOTECH TARGET N V | 10% Owner | P Buy | 2020-10-28 | 2020-11-04 | 80,000 | $9.40 | $752.0K | 5,149,996 | SEC↗ |
| SHV Annex Services, LP | 10% Owner | S Sale | 2020-09-16 | 2020-09-18 | 500,000 | $13.05 | $6.53M | 6,097,298 | SEC↗ |
| LALANDE KEVIN M. | Director, 10% Owner | S Sale | 2020-09-16 | 2020-09-18 | 500,000 | $13.05 | $6.53M | 6,097,298 | SEC↗ |
| Longitude Venture Partners III | 10% Owner | S Sale | 2020-08-28 | 2020-09-01 | 1,049 | $10.75 | $11.3K | 0 | SEC↗ |
| Longitude Venture Partners III | 10% Owner | S Sale | 2020-08-28 | 2020-09-01 | 2,447 | $10.75 | $26.3K | 0 | SEC↗ |
| Sanders Corazon (Corsee) D. | Director | A Award deriv | 2020-05-28 | 2020-06-01 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Morenstein Scott D | Director | A Award deriv | 2020-05-28 | 2020-06-01 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Hirsch David | Director, 10% Owner | A Award deriv | 2020-05-28 | 2020-06-01 | 15,000 | — | $0 | 15,000 | SEC↗ |
| LALANDE KEVIN M. | Director, 10% Owner | A Award deriv | 2020-05-28 | 2020-06-01 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SELICK HAROLD E | Director | A Award deriv | 2020-05-28 | 2020-06-01 | 15,000 | — | $0 | 15,000 | SEC↗ |
| HOFFMANN DAVE | Director | A Award deriv | 2020-05-28 | 2020-06-01 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ENRIGHT PATRICK G | 10% Owner | J Other | 2020-05-26 | 2020-05-28 | 1,000,000 | — | $0 | 3,199,035 | SEC↗ |
| ENRIGHT PATRICK G | 10% Owner | J Other | 2020-05-26 | 2020-05-28 | 3,495 | — | $0 | 3,495 | SEC↗ |
| ENRIGHT PATRICK G | 10% Owner | J Other | 2020-05-26 | 2020-05-28 | 2,447 | — | $0 | 2,447 | SEC↗ |
| ENRIGHT PATRICK G | 10% Owner | J Other | 2020-05-26 | 2020-05-28 | 1,049 | — | $0 | 1,049 | SEC↗ |
| Hirsch David | Director, 10% Owner | J Other | 2020-05-26 | 2020-05-28 | 1,000,000 | — | $0 | 3,199,035 | SEC↗ |
| Hirsch David | Director, 10% Owner | J Other | 2020-05-26 | 2020-05-28 | 1,649 | — | $0 | 1,649 | SEC↗ |
| SHV Management Services, LLC | 10% Owner | S Sale | 2020-05-20 | 2020-05-22 | 300,000 | $16.51 | $4.95M | 6,597,298 | SEC↗ |
| LALANDE KEVIN M. | Director, 10% Owner | S Sale | 2020-05-20 | 2020-05-22 | 300,000 | $16.51 | $4.95M | 6,597,298 | SEC↗ |
| SANTE HEALTH VENTURES I LP | 10% Owner | J Other | 2020-04-30 | 2020-05-04 | 1,000,000 | — | $0 | 6,897,298 | SEC↗ |
| LALANDE KEVIN M. | Director, 10% Owner | J Other | 2020-04-30 | 2020-05-04 | 1,000,000 | — | $0 | 6,897,298 | SEC↗ |
| Kim Jason S. | See remarks | A Award deriv | 2020-02-14 | 2020-02-18 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Poma Eric E | See remarks | A Award deriv | 2020-02-14 | 2020-02-18 | 312,500 | — | $0 | 312,500 | SEC↗ |
| Cutler Adam D. | See remarks | A Award deriv | 2020-02-14 | 2020-02-18 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Waltzman Roger J. | Chief Medical Officer | A Award deriv | 2020-02-14 | 2020-02-18 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Kim Jason S. | See Remarks | M Exercise deriv | 2020-01-03 | 2020-01-03 | 54,136 | — | $0 | 0 | SEC↗ |
| Kim Jason S. | See Remarks | M Exercise | 2020-01-03 | 2020-01-03 | 54,136 | $0.42 | $22.7K | 54,136 | SEC↗ |
| Sanders Corazon (Corsee) D. | Director | A Award deriv | 2019-12-19 | 2019-12-20 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Hirsch David | Director, 10% Owner | P Buy | 2019-11-25 | 2019-11-27 | 937,000 | $8.00 | $7.50M | 4,198,535 | SEC↗ |
| Longitude Capital Partners III | 10% Owner | P Buy | 2019-11-25 | 2019-11-27 | 937,000 | $8.00 | $7.50M | 4,198,535 | SEC↗ |
| Longitude Venture Partners III | 10% Owner | P Buy | 2019-11-25 | 2019-12-05 | 937,500 | $8.00 | $7.50M | 4,199,035 | SEC↗ |
| Hirsch David | Director, 10% Owner | P Buy | 2019-11-25 | 2019-12-05 | 937,500 | $8.00 | $7.50M | 4,199,035 | SEC↗ |
| Morenstein Scott D | Director | P Buy | 2019-11-21 | 2019-11-25 | 468,750 | $8.00 | $3.75M | 2,052,991 | SEC↗ |
| Hirsch David | Director, 10% Owner | A Award deriv | 2019-05-29 | 2019-05-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SELICK HAROLD E | Director | A Award deriv | 2019-05-29 | 2019-05-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Morenstein Scott D | Director | A Award deriv | 2019-05-29 | 2019-05-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| HOFFMANN DAVE | Director | A Award deriv | 2019-05-29 | 2019-05-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| LALANDE KEVIN M. | Director, 10% Owner | A Award deriv | 2019-05-29 | 2019-05-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Waltzman Roger J. | SVP, Chief Medical Officer | A Award deriv | 2019-02-19 | 2019-02-21 | 175,000 | — | $0 | 175,000 | SEC↗ |
| Kim Jason S. | See Remarks | A Award deriv | 2019-02-15 | 2019-02-20 | 130,000 | — | $0 | 130,000 | SEC↗ |
| Poma Eric E | See remarks | A Award deriv | 2019-02-15 | 2019-02-20 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Cutler Adam D. | See remarks | A Award deriv | 2019-02-15 | 2019-02-20 | 92,000 | — | $0 | 92,000 | SEC↗ |
| CAXTON CORP | Director | P Buy | 2018-12-26 | 2018-12-28 | 25,000 | $3.45 | $86.3K | 1,584,241 | SEC↗ |
| Poma Eric E | See Remarks | M Exercise deriv | 2018-11-26 | 2018-11-29 | 86,951 | — | $0 | 3,563 | SEC↗ |
| Poma Eric E | See Remarks | M Exercise deriv | 2018-11-26 | 2018-11-29 | 152,945 | — | $0 | 0 | SEC↗ |
| Poma Eric E | See Remarks | M Exercise | 2018-11-26 | 2018-11-29 | 152,945 | $0.42 | $64.2K | 152,945 | SEC↗ |
| Poma Eric E | See Remarks | M Exercise | 2018-11-26 | 2018-11-29 | 86,951 | $0.71 | $61.7K | 239,896 | SEC↗ |
| Morenstein Scott D | Director | P Buy | 2018-09-25 | 2018-09-27 | 545,454 | $5.50 | $3.00M | 1,559,241 | SEC↗ |
| Hirsch David | Director, 10% Owner | P Buy | 2018-09-21 | 2018-09-25 | 365,000 | $5.50 | $2.01M | 3,261,535 | SEC↗ |
| Tammenoms Bakker Juliet | 10% Owner | P Buy | 2018-09-21 | 2018-09-25 | 365,000 | $5.50 | $2.01M | 3,261,535 | SEC↗ |
| Poma Eric E | See Remarks | A Award deriv | 2018-05-31 | 2018-07-13 | 585,126 | — | $0 | 585,126 | SEC↗ |
| Kim Jason S. | See Remarks | A Award deriv | 2018-05-31 | 2018-07-13 | 196,161 | — | $0 | 196,161 | SEC↗ |
| Cutler Adam D. | See Remarks | A Award deriv | 2018-05-31 | 2018-06-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Hirsch David | Director, 10% Owner | A Award deriv | 2018-05-31 | 2018-06-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SELICK HAROLD E | Director | A Award deriv | 2018-05-31 | 2018-06-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| HOFFMANN DAVE | Director | A Award deriv | 2018-05-31 | 2018-06-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| LALANDE KEVIN M. | Director, 10% Owner | A Award deriv | 2018-05-31 | 2018-06-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Morenstein Scott D | Director | A Award deriv | 2018-05-31 | 2018-06-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Kim Jason S. | See Remarks | A Award deriv | 2018-05-31 | 2018-06-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Poma Eric E | See Remarks | A Award deriv | 2018-05-31 | 2018-06-04 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Cutler Adam D. | CFO and Treasurer | A Award deriv | 2017-11-13 | 2017-11-15 | 225,000 | — | $0 | 225,000 | SEC↗ |
| SELICK HAROLD E | Director | A Award deriv | 2017-10-09 | 2017-10-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| HOFFMANN DAVE | Director | A Award deriv | 2017-10-09 | 2017-10-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Morenstein Scott D | Director | A Award deriv | 2017-10-09 | 2017-10-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Kim Jason S. | See Remarks | A Award deriv | 2017-10-09 | 2017-10-11 | 137,500 | — | $0 | 137,500 | SEC↗ |
| Poma Eric E | See Remarks | A Award deriv | 2017-10-09 | 2017-10-11 | 275,000 | — | $0 | 275,000 | SEC↗ |
| LALANDE KEVIN M. | Director, 10% Owner | A Award deriv | 2017-10-09 | 2017-10-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Hirsch David | Director, 10% Owner | A Award deriv | 2017-10-09 | 2017-10-11 | 25,000 | — | $0 | 25,000 | SEC↗ |